Redcliffe Labs appoints Vijay T. S. as Chief People Officer
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term
Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
Subscribe To Our Newsletter & Stay Updated